AYTU BioPharma
AYTU
AYTU
22 hedge funds and large institutions have $5.03M invested in AYTU BioPharma in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
13.85% less ownership
Funds ownership: 45.64% → 31.79% (-14%)
Holders
22
Holding in Top 10
–
Calls
$232K
Puts
–
Top Buyers
| 1 | +$46.9K | |
| 2 | +$40.5K | |
| 3 | +$39.4K | |
| 4 |
Renaissance Technologies
New York
|
+$23.3K |
| 5 |
JPMorgan Chase & Co
New York
|
+$13.2K |
Top Sellers
| 1 | -$22.2K | |
| 2 | -$11.1K | |
| 3 | -$9.86K | |
| 4 |
BlackRock
New York
|
-$3.6K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$297 |